Subsequent Events |
12 Months Ended |
|---|---|
Dec. 31, 2024 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS |
NOTE 11 - SUBSEQUENT EVENTS
In January 2025, the Company received a contingent payment with respect to CollPlant’s rhCollagen, which, according to the AbbVie Development Agreement, triggers a $2,000 payment from AbbVie to CollPlant. The payment received and recognized as revenue in the first quarter of 2025. |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|